APPLICATION
ANDA076071
TYPE
ANDA
ORIGINAL APPROVAL
2002-07-01
LATEST ACTION
2024-04-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
LISINOPRILDiscontinued
LISINOPRIL 2.5MG · TABLET · ORAL
LISINOPRILDiscontinued
LISINOPRIL 40MG · TABLET · ORAL
LISINOPRILDiscontinued
LISINOPRIL 20MG · TABLET · ORAL
LISINOPRILDiscontinued
LISINOPRIL 5MG · TABLET · ORAL
LISINOPRILDiscontinued
LISINOPRIL 30MG · TABLET · ORAL
LISINOPRILDiscontinued
LISINOPRIL 10MG · TABLET · ORAL
Approval history
2024-04-11Labeling · Supplement 34 · standardAP
2016-09-08Labeling · Supplement 32 · standardAP
2015-12-26Labeling · Supplement 31 · standardAP
2015-06-13Labeling · Supplement 24 · standardAP
2015-06-13Labeling · Supplement 27 · standardAP
2015-06-13Labeling · Supplement 25 · standardAP
2013-03-01Labeling · Supplement 20AP
2013-03-01Labeling · Supplement 23 · standardAP
2013-03-01Labeling · Supplement 21 · standardAP
2010-03-08Labeling · Supplement 19AP
2009-10-16Labeling · Supplement 17AP
2008-02-21Labeling · Supplement 8AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.